POPULATION'S PERCEPTION ABOUT VACCINES FROM GENE ENGINEERING TECHNIQUES AND AGAINST COVID-19

Authors

DOI:

https://doi.org/10.47820/recima21.v3i8.1842

Keywords:

Genetic Engineering, Vaccination, SARS-CoV-2

Abstract

The objective of this work was to obtain the perception of the population about: 1) the importance of immunization; 2) knowledge of methodologies (genetic manipulation) used for vaccine production; 3) acceptance of the vaccine against COVID-19. To this end, an online questionnaire produced via Google Forms was made available. This form was disseminated in various virtual environments such as academic and social media. Over six months, 353 responses were obtained. In this survey, responses were obtained from participants residing in 14 states in Brazil. Considering the investigation about vaccines, the results showed that most (90.6%) have already been vaccinated, as well as their families, and understand the importance of immunization. The techniques of genetic manipulation are complex and more widespread in the scientific environment, so it was observed that a large part of the interviewed population does not have an opinion on the subject. The research showed that because of the state of calamity caused by the pandemic, people had urgency in immunization, even with distrust in aspects such as efficiency. Currently, it is clear that vaccination does not prevent infection with the virus, but minimizes the damage caused by the infection. Data from the Ministry of Health show that the number of cases and deaths has reduced by more than 40%, showing once again the effectiveness and necessity of immunization of the population.

Downloads

Download data is not yet available.

Author Biographies

Victória Caixeta Santos e Oliveira

Acadêmica do Curso de Medicina da Universidade José do Rosário Vellano (UNIFENAS), Alfenas-MG, Brasil.

Karine Alonso dos Santos

Acadêmica do Curso de Medicina da Universidade José do Rosário Vellano (UNIFENAS), Alfenas-MG, Brasil.

Rafaela Gontijo Lima

Acadêmica do Curso de Medicina da Universidade José do Rosário Vellano (UNIFENAS), Alfenas-MG, Brasil.

Danielly Beraldo dos Santos Silva

Professora do Curso de Medicina da Universidade José do Rosário Vellano (UNIFENAS), Alfenas-MG, Brasil.

References

AGÊNCIA BRASIL. Ministro diz que é possível vacinar toda população brasileira em 2021. Disponível em: https://agenciabrasil.ebc.com.br/saude/noticia/2021-05/ministro-diz-que-e-possivel-vacinar-toda-populacao-brasileira-em-2021. Acesso em: 12 ago. 2021.

APS, Luana Raposo de Melo Moraes et al. Adverse events of vaccines and the consequences of non-vaccination: a critical review. Revista de Saúde Pública [online], v. 52, p.40, 2018.

AZEGAMI, Tatsuhiko; YUKI, Yoshikazu; KIYONO, Hiroshi. Plant-based mucosal vaccine delivery systems: Innovation for Preventing Infectious Diseases. 2. ed. [S.l.]: Elsevier, 2019. p. 357-370.

CARROLL et al. Introdução à genética. 11. ed. Rio de Janeiro: Guanabara Koogan,, 2016.

CENTERS FOR DISEASE CONTROL AND PREVENTION. Delta Variant: What We Know About the Science. Disponível em: https://www.cdc.gov/coronavirus/2019-ncov/variants/delta-variant.html. Acesso em: 11 ago. 2021.

CHEN et al. The SARS-CoV-2 Vaccine Pipeline: an Overview. Current Tropical Medicine Reports, California, v. 7, n. 7, p. 61-64, mar./2022.

CNN BRASIL. Podemos ter que vacinar contra Covid-19 todos os anos. Disponível em: https://www.cnnbrasil.com.br/saude/queiroga-a-cnn-podemos-ter-que-vacinar-contra-covid-19-todos-os-anos/. Acesso em: 12 ago. 2021.

CNN POLITICS. The data shows Americans are going out at highest levels in a year. Disponível em: https://edition.cnn.com/2021/05/01/politics/pandemic-return-to-activities-analysis/index.html. Acesso em: 11 ago. 2021.

CÂMARA MUNICIPAL DE SÃO PAULO. PL que coloca no fim da fila quem recusar vacina da Covid-19 em razão da marca tem parecer aprovado. Disponível em: https://www.saopaulo.sp.leg.br/blog/pl-que-coloca-no-fim-da-fila-quem-recusar-vacina-da-covid-19-em-razao-da-marca-tem-parecer-aprovado/. Acesso em: 12 ago. 2021.

DATASUS. Ministério da Saúde (BR), Departamento de Informática do Sistema Único de Saúde (DATASUS). Informações de saúde (TABNET). . Disponível em: http://www2.datasus.gov.br/DATASUS/index.php. Acesso em: 23 mar. 2021.

DOMINGUES, C. M. A. S; TEIXEIRA, A. M. D. S. Coberturas vacinais e doenças imunopreveníveis no Brasil no período 1982-2012: avanços e desafios do Programa Nacional de Imunizações. Epidemiologia e Serviços de Saúde, Brasília, v. 22, n. 1, p. 9-27, mar./2013.

ELBEHRI, Aziz. Biopharming and the Food System: Examining the Potential Benefits and Risks. AgBioForum, United States, v. 8, n. 1, p. 18-25, mar./2005. Disponível em: https://mospace.umsystem.edu/xmlui/bitstream/handle/10355/125/Biopharming%20and%20the%20food%20system.pdf?sequence=1&isAllowed=y. Acesso em: 25 mai. 2020.

FUNDAÇÃO OSWALDO CRUZ. Vacina COVID-19 (recombinante). Disponível em: https://www.bio.fiocruz.br/index.php/br/produtos/vacinas/covid-19-recombinante. Acesso em: 17 jan. 2022.

GERALDINI, M. et al. Alérgenos recombinantes na prática da imunoterapia. Revista Brasileira de Alergia e Imunopatologia, São Paulo, v. 31, n. 3, p. 92-97, abr./2008.

HARVEY, David. The condition of postmodernity. 1. ed. Oxford: Blackwell, 1992.

HOMMA, Akira. Desenvolvimento tecnológico: Desenvolvimento tecnológico: elo deficiente na inovação tecnológica de vacinas no Brasil. Hist. cienc. saude-Manguinhos, Rio de Janeiro, v. 10, n. 2, p. 671-696, jun./2003.

HOWELL, Emily L et al. National Academies of Sciences, Engineering, and Medicine report on genetically engineered crops influences public discourse. Politics and the life sciences: the journal of the Association for Politics and the Life Sciences, v. 37, n.2, p.250-261, 2018. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31120702/. Acesso 10 out. 2021.

IMPERIAL COLLEGE LONDON. Estimating COVID-19 cases and reproduction number in Brazil. Disponível em: https://spiral.imperial.ac.uk/handle/10044/1/78872. Acesso em: 5 out. 2020.

INFORME ENSP. Como interpretar os benefícios das vacinas contra a Covid-19?. Disponível em: http://informe.ensp.fiocruz.br/noticias/50665. Acesso em: 5 out. 2021.

INSTITUTO BUTANTAN. Quais são as diferenças entre as vacinas contra Covid-19 que estão sendo aplicadas no Brasil?. Disponível em: https://butantan.gov.br/covid/butantan-tira-duvida/tira-duvida-noticias/quais-sao-as-diferencas-entre-as-vacinas-contra-covid-19-que-estao-sendo-aplicadas-no-brasil. Acesso em: 17 jan. 2022.

KARA-JUNIOR, Newton. A democratização do conhecimento médico e seus desafios. Revista Brasileira de Oftalmologia, Rio de Janeiro, v. 72, n. 1, p. 5-7, ago./2013.

LI, Q. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine, Massachusetts, v. 382, n. 13, p. 1199-1207, jan./2020.

MANTOVANI, E. et al. Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?. Journal of NeuroVirology , Itália, v. 27, n. 4, p. 631-637, ago./2021.

MASON, H S; LAM, D M; ARNTZEN, C J. Expression of hepatitis B surface antigen in transgenic plants.. Proceedings of the National Academy of Sciences, USA, v. 89, n. 24, p. 11745-11749, dez./1992.

MCKIBBIN, Warwick; FERNANDO, Roshen. Economics in the Time of COVID-19: The economic impact of COVID-19. 1. ed. London: CEPR Press, 2020. p. 45-53.

MINISTÉRIO DA SAÚDE (BR). Plano Nacional de Operacionalização da Vacinação contra a COVID-19. Disponível em: https://www.gov.br/saude/pt-br/coronavirus/publicacoes-tecnicas/guias-e-planos/plano-nacional-de-vacinacao-covid-19/view. Acesso em: 12 ago. 2021.

MINISTÉRIO DA SAÚDE (BR). Sarampo: situação epidemiológica. Disponível em: http://portalms.saude.gov.br/saude-de-a-z/sarampo-situacao-epidemiologica. Acesso em: 23 mar. 2021.

MINITÉRIO DA SAÚDE. PAINEL CORONAVIRUS. Disponível em: https://covid.saude.gov.br/. Acesso em: 27 mai. 2020.

MIZUTA, A. H. et al. Percepções acerca da importância das vacinas e da recusa vacinal numa escolar de medicina. Revista Paulista de Pediatria, São Paulo, v. 37, n. 1, p. 34-40, jan./2019.

MOURA, D. L. et al. Sequelas da COVID-19: Evidência Atual. Rev Med Desportiva informa, Coimbra, v. 12, n. 3, p. 8-11, jun./2021.

MUJJASSIM, N. E. et al. Cisgenesis and intragenesis a new tool for conventional plant breeding: A review. Journal of Pharmacognosy and Phytochemistry, India, v. 8, n. 1, p. 2485-2489, mai./2019.

NERKAR, G. et al. Advances in Plant Transgenics: Methods and Applications: Key Challenges in Developing Products from Transgenic Plants. 1. ed. Singapore: Springer , 2019. p. 315-333.

O GLOBO. Grupo recruta voluntários para se infectarem de propósito com Covid-19 em estudo de vacina. Disponível em: https://oglobo.globo.com/sociedade/coronavirus/grupo-recruta-voluntarios-para-se-infectarem-de-proposito-com-covid-19-em-estudo-de-vacina-24388273. Acesso em: 28 mai. 2020.

OUR WORLD IN DATA. Coronavirus (COVID-19) Vaccinations. Disponível em: https://ourworldindata.org/covid-vaccinations. Acesso em: 4 out. 2021.

PIMENTA, C. A. M; LIMA, J. M. D. Genética aplicada à biotecnologia. 1. ed. São Paulo: Érica, 2015.

PINTO, B. G. G. et al. ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19. The Journal of Infectious Diseases, São Paulo, v. 222, n. 4, p. 556-563, ago./2020.

PORTAL BRASILEIRO DE DADOS ABERTOS. Pesquisa Nacional por Amostra de Domicílios Contínua Anual - PNADC/A 2019. Disponível em: https://dados.gov.br/dataset/pesquisa-nacional-por-amostra-de-domicilios-continua-anual-pnadc-a. Acesso em: 23 mai. 2020.

PROMPETCHARA, Eakachai; KETLOY, Chutitorn; PALAGA, Tanapat. Immune responses in COVID-19 and potential vaccines:: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology, Thailand, v. 38, n. 1, p. 1-8, mar./2020.

QUINTELLA, C. M. et al. Vacinas para Coronavírus (COVID-19; SARSCOV-2): mapeamento preliminar de artigos, patentes, testes clínicos e mercado. Cadernos de Prospecção, Salvador, v. 13, n. 1, p. 3-12, mar./2020.

SATO, A. P. S. Qual a importância da hesitação vacinal na queda das coberturas vacinais no Brasil? . Revista de Saúde Pública, São Paulo, v. 52, n. 96, p. 1-9, out./2018.

SCIENCES, T. N. A. O; ENGINEERING; MEDICINE, And. Genetically engineered crops: experiences and prospects. . 1. ed. Washington: The National Academies Press, 2016. p. 10-125.

SECRETARIA DO ESTADO DE SAÚDE DE MINAS GERAIS. Painel Vacinômetro. Disponível em: https://coronavirus.saude.mg.gov.br/vacinometro. Acesso em: 22 mar. 2021.

SILVA, Penildon. Farmacologia. 8. ed. Rio de Janeiro: Grupo GEN, 2010. p. 277-978.

TACKET, C. O. Plant-Based Oral Vaccines: Results of Human Trials. Current Topics In Microbiology And Immunolog, Berlin, v. 332, n. 1, p. 113-117, set./2009.

TIME. Inside the Company That's Hot-wiring Vaccine Research in the Race to Combat the Coronavirus. Disponível em: https://time.com/5775784/coronavirus-vaccine-research. Acesso em: 28 mai. 2020.

Published

20/08/2022

How to Cite

Santos e Oliveira, V. C., Santos, K. A. dos ., Lima, . R. G. ., & Silva, D. B. dos S. . (2022). POPULATION’S PERCEPTION ABOUT VACCINES FROM GENE ENGINEERING TECHNIQUES AND AGAINST COVID-19. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 3(8), e381842. https://doi.org/10.47820/recima21.v3i8.1842